WallStreetZenWallStreetZen

NYSE: CTRE
Caretrust Reit Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CTRE

Based on 9 analysts offering 12 month price targets for Caretrust Reit Inc

Min Forecast
$40.00-4.03%
Avg Forecast
$43.11+3.43%
Max Forecast
$48.00+15.16%

Should I buy or sell CTRE stock?

Based on 9 analysts offering ratings for Caretrust Reit Inc.

Strong Buy
Strong Buy
4 analysts 44.44%
Buy
4 analysts 44.44%
Hold
1 analysts 11.11%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although CTRE's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates CTRE as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their CTRE stock forecasts and price targets.

CTRE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-04-02
lockedlocked$00.00+00.00%2026-03-26Find Out Why
lockedlocked$00.00+00.00%2026-02-24
lockedlocked$00.00+00.00%2026-02-18
lockedlocked$00.00+00.00%2026-02-17
Citizens
Top 27%
74
BuyInitiates Coverage On$44.00+5.57%2026-01-22
BMO Capital
Top 26%
75
BuyUpgrades$43.00+3.17%2026-01-09
Jefferies
Top 39%
62
Strong BuyMaintains$43.00+3.17%2025-12-16
KeyBanc
Top 15%
86
Strong BuyMaintains$40.00-4.03%2025-12-04Find out why

1 of 1

Forecast return on equity

Is CTRE forecast to generate an efficient return?

Company
9.58%
Industry
5.96%
Market
146.44%
CTRE's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CTRE forecast to generate an efficient return on assets?

Company
7.56%
Industry
3.6%
CTRE is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CTRE earnings per share forecast

What is CTRE's earnings per share in the next 3 years based on estimates from 10 analysts?

Avg 1 year Forecast
$1.51-4.22%
Avg 2 year Forecast
$1.59+0.61%
Avg 3 year Forecast
$1.68+6.09%
CTRE's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

CTRE revenue forecast

What is CTRE's revenue in the next 3 years based on estimates from 12 analysts?

Avg 1 year Forecast
$517.2M-1.03%
Avg 2 year Forecast
$592.1M+13.32%
Avg 3 year Forecast
$618.9M+18.44%
CTRE's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CTRE earnings growth forecast

How is CTRE forecast to perform vs REIT - Healthcare Facilities companies and vs the US market?

Company
0.4%
Industry
21.62%
Market
67.2%
CTRE's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
CTRE's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
CTRE's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

CTRE revenue growth forecast

How is CTRE forecast to perform vs REIT - Healthcare Facilities companies and vs the US market?

Company
5.27%
Industry
10.87%
Market
16.29%
CTRE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CTRE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CTRE vs Healthcare Facility REIT Stocks

TickerPricePrice TargetUp/downsideConsensus
CTRE$41.68$43.11+3.43%Strong Buy
AHR$50.46$57.00+12.96%Buy
HR$20.20$21.50+6.44%Buy
DOC$19.87$19.33-2.70%Buy
OHI$47.73$49.11+2.89%Buy
View Top Healthcare Facility REIT Stocks

Caretrust Reit Stock Forecast FAQ

Is Caretrust Reit Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NYSE: CTRE) stock is to Strong Buy CTRE stock.

Out of 9 analysts, 4 (44.44%) are recommending CTRE as a Strong Buy, 4 (44.44%) are recommending CTRE as a Buy, 1 (11.11%) are recommending CTRE as a Hold, 0 (0%) are recommending CTRE as a Sell, and 0 (0%) are recommending CTRE as a Strong Sell.

If you're new to stock investing, here's how to buy Caretrust Reit stock.

What is CTRE's earnings growth forecast for 2026-2028?

(NYSE: CTRE) Caretrust Reit's forecast annual earnings growth rate of 0.4% is not forecast to beat the US REIT - Healthcare Facilities industry's average forecast earnings growth rate of 21.62%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 67.2%.

Caretrust Reit's earnings in 2026 is $334,946,000.On average, 10 Wall Street analysts forecast CTRE's earnings for 2026 to be $357,525,972, with the lowest CTRE earnings forecast at $319,491,294, and the highest CTRE earnings forecast at $386,961,505. On average, 10 Wall Street analysts forecast CTRE's earnings for 2027 to be $375,551,102, with the lowest CTRE earnings forecast at $321,806,448, and the highest CTRE earnings forecast at $409,286,207.

In 2028, CTRE is forecast to generate $395,985,882 in earnings, with the lowest earnings forecast at $365,794,380 and the highest earnings forecast at $426,649,864.

What is CTRE's revenue growth forecast for 2026-2028?

(NYSE: CTRE) Caretrust Reit's forecast annual revenue growth rate of 5.27% is not forecast to beat the US REIT - Healthcare Facilities industry's average forecast revenue growth rate of 10.87%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.29%.

Caretrust Reit's revenue in 2026 is $522,555,000.On average, 12 Wall Street analysts forecast CTRE's revenue for 2026 to be $122,176,362,335, with the lowest CTRE revenue forecast at $99,629,594,307, and the highest CTRE revenue forecast at $161,656,830,408. On average, 12 Wall Street analysts forecast CTRE's revenue for 2027 to be $139,887,292,753, with the lowest CTRE revenue forecast at $101,637,636,304, and the highest CTRE revenue forecast at $189,190,629,797.

In 2028, CTRE is forecast to generate $146,218,531,051 in revenue, with the lowest revenue forecast at $140,482,618,145 and the highest revenue forecast at $150,518,103,328.

What is CTRE's forecast return on assets (ROA) for 2026-2028?

(NYSE: CTRE) forecast ROA is 7.56%, which is higher than the forecast US REIT - Healthcare Facilities industry average of 3.6%.

What is CTRE's Price Target?

According to 9 Wall Street analysts that have issued a 1 year CTRE price target, the average CTRE price target is $43.11, with the highest CTRE stock price forecast at $48.00 and the lowest CTRE stock price forecast at $40.00.

On average, Wall Street analysts predict that Caretrust Reit's share price could reach $43.11 by Apr 2, 2027. The average Caretrust Reit stock price prediction forecasts a potential upside of 3.43% from the current CTRE share price of $41.68.

What is CTRE's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: CTRE) Caretrust Reit's current Earnings Per Share (EPS) is $1.58. On average, analysts forecast that CTRE's EPS will be $1.51 for 2026, with the lowest EPS forecast at $1.35, and the highest EPS forecast at $1.64. On average, analysts forecast that CTRE's EPS will be $1.59 for 2027, with the lowest EPS forecast at $1.36, and the highest EPS forecast at $1.73. In 2028, CTRE's EPS is forecast to hit $1.68 (min: $1.55, max: $1.81).

What is CTRE's forecast return on equity (ROE) for 2026-2028?

(NYSE: CTRE) forecast ROE is 9.58%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.